Thyroid disorders, vitamin D, and sugar accumulation effects in polycystic ovary syndrome
DOI:
https://doi.org/10.59743/Keywords:
polycystic ovary syndrome , infertility center Misurata , LibyaAbstract
.
Downloads
References
فراس طاهر ماهر، نبأ هيثم احمد. (2014). دراسة هرمونية وكيموحيوية في عدد من النساء المصابات بمتلازمة تكيس المبايض في محافظة ديالى. رسالة ماجستير، كلية العلوم, جامعة تكريت.1-17 .
Altuntas, C.Z. Johnson, J.M. and Tuohy, V.K. (2006). "Autoimmune targeted disruption of the pituitary-ovarian axis causes premature ovarian failure" J. Immunol .177(3):1988-6.
Asuncion, M.; Calvo, R.M.; et al. (2000)."Aprospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain" J. Clin. Endocrinol. Metab.85(7):2434-8.
Azziz R. (2018). Reproductive endocrinology and infertility: Clinical expert series polycystic ovary syndrome. Obstetrics and Gynecology.132(2):321–36.
Barbieri, R.L. (2007). "Polycystic Ovary syndrome" .
Buccola JM, Reynolds EE. (2003). Polycystic ovary syndrome: a review for primary providers. Prim Care.30:697-710.
Cecil. (2002). Thyroid gland in: essential of medicine Edited byE.B-Sounder company. P:1227-1244.
Crespo RP, Bachega TASS, Mendonça BB, Gomes LG.(2018). An update of genetic basis of PCOS pathogenesis. Archives of Endocrinology and Metabolism. 62(3):352–61..
Diamanti-Kandarakis E., Dunaif A. (2012). Insulin resistance and the polycystic ovary syndrome revisited: An update on mechanisms and implications. Endocr. Rev.33:981–1030.
Gambineri A, Pelusi C, Vicennati V, Pagotto U, Pasquali R. (2002). Obesity and the polycystic ovary syndrome. Int J Obes Relat Metab Disord; 26:883– 896.
He C, Lin Z, Robb SW, Ezeamama AE. (2015). Serum vitamin D levels and polycystic ovary syndrome: a systematic review and Meta-analysis. Nutrients. 7(6):4555–77.
Huang R, Zheng J, Li S, Tao T, Liu W. (2014). Subclinical hypothyroidism in patients with polycystic ovary syndrome: distribution and its association with lipid profiles. Eur J Obstet Gynecol Reprod Biol. 177:52–6.
Hunter MH, Sterrett JJ. (2000). Polycystic Ovary Syndrome: It's Not Just Infertility. Am Fam Physician. 62(5):1079-1088.
Kazer, R.R.; Kassel, B.and Yen, S.S. (1987). "Circulating Latinizing hormone pulse frequency in women with Polycystic Ovary Syndrome" J. Clin. Endocrinol. Metab. 65:233-236.
Lane, D.E. (2006)."Polycystic Ovary Syndrome and its differential diagnosis" Obstet. Gynecol. Surv. 61(2):125-35.
Liu YN, Qin Y, Wu B, Peng H, Li M, Luo H, Liu LL. (2022). DNA methylation in polycystic ovary syndrome: Emerging evidence and challenges.Reproductive Toxicology.111(April):11–9.
Lin, M.W.; Wu, M.H. (2015). The role of vitamin D in polycystic ovary syndrome. Indian J. Med. Res. 142, 238–240.
Louck, T.L.; Talbott, E.O. et al. (2000). "DoPolycystic-appearing ovaries affect the risk of cardiovascular disease among women with Polycystic Ovary Syndrome?" Fertile. Sterile.74(3):547-52.
Louis, V. (2007). "Polycystic Ovary Syndrome (PCOS)" U.S.Department of Health and Human Services, office on Women's Health.1-6.
Micheal,; T.M.C and Dermott, M.D.(2002). Hypothyrodism , Endocrine secrets , Thired Edition .Hanley & Belfus , INC.33:P:208-212.
Najem FI, Elmehdawi RR, Swalem AM. (2008). Clinical and Biochemical Characteristics of Polycystic Ovary Syndrome in Benghazi-Libya; A Retrospective study. Libyan Journal of Medicine. 3(2):71–4.
Neilson JP, Alfirevic Z. (2006). Should obese women with polycystic ovary syndrome receive treatment for infertility? BMJ.332(February):434–5..
Nestler JE. (2000). Obesity, insulin, sex steroids and ovulation. Int J Obes Relat Metab Disord;24: S71–S73.
Norman RJ, Dewailly D, Legro RS, Hickey TE. (2007). Polycystic ovary syndrome. Lancet. 370:685-97.
Polak ,G.;Koziol – Montewka , M.,Gogacz.M.,Blasz Kowska , I. and ,Kotarski , J .(2001) .(( Total anti-oxidant status of peritoneal fluid in infertile women)) .Eur.J.obstet .Gynecol Reprod Biol . 94(2) :P:261-263.
Randall, V.A.; Thorton, M. S.; Hamada, K. and Messanger, A. (1992). Mechanism of androgen action in Cultured dermal papilla cells derived from human hair follicles in varying response to androgen in Vivo; J.Inves . Dermatol.98:P:865-915.
Randall, V.A.; Thorton, M. S.; Hamada, K. and Messanger, A. (2009). Androgen Action in Cultured Dermal Papilla Cells from Human Hair Follicles. RESEARCH ARTICLES. 7 (1-2): 20–26.
Reinehr T, Andler W. (2002). Thyroid hormones before and after weight loss in obesity. Arch Dis Child; 87:320 – 323.
Reinehr T, de Sousa G, Andler W. (2006). Hyperthyrotropinemia in obese children is reversible after weight loss and is not related to lipids. J Clin Endocrinol Metab; 91:3088 – 3091.
Reinehr T, Isa A, de Sousa G, Dieffenbach R, Andler W. (2008). Thyroid hormones and their relation to weight status. Horm Res;70: 51 – 47.
Richardson MR. (2003). Current Perspectives in Polycystic Ovary Syndrome. Am Fam Physician. 68(4):697- 704.
Siam SG, Soliman BS, Ali MR, Abdallah OAM. (2020). Prevalence of polycystic ovarian syndrome in young adult unmarried females attending zagazig university hospital outpatient clinic. Egyptian Journal of Hospital Medicine. 81(6):2152–9.
Stepto NK, Cassar S, Joham AE, Hutchison SK, Harrison CL, Goldstein RF, Teede HJ. (2013). Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic–hyperinsulaemic clamp. Hum. Reprod. 28, 777–784..
Vaidya A, Yadav S, Vaidya A. (2020). Study on the Clinical and Hormonal Profile of polycystic ovarian syndrome patients attending a Tertiary Care Hospital: a descriptive cross-sectional study. JNMA J Nepal Med Assoc. 58(231):875–88.
Vink, J. M., Sadrzadeh, S., Lambalk, C. B. & Boomsma, D. I. (2006). Heritability of polycystic ovary syndrome in a Dutch twin-family study. J. Clin. Endocrinol. Metab. 91, 2100–2104..
Teede, HJ, Tay CT, Laven J, Dokras A, Moran LJ, Piltonen TT, Costello MF, Boivin J, M Redman L, A Boyle J, Norman RJ, Mousa A, Joham AE. (2023). Recommendations from the. International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. 10.1016. 07.025.
Wekker V, van Dammen L, Koning A, Heida KY, Painter RC, Limpens J. (2020). Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis. Hum Reprod Update. 26(6):942–60.
Witchel SF, Oberfield SE, Peña AS. (2019). Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment with Emphasis on Adolescent Girls. Journal of the Endocrine Society.3(8):1545–73.
Yarak S, Bagatin E, Hassun KM, Talarico S. (2005). Parada MOA. Hyperandrogenism and skin: polycystic ovary syndrome and peripheral insulin resistance. An Bras Dermatol. 80:16.
Yao K, Bian C, Zhao X. (2017). Association of polycystic ovary syndrome with metabolic syndrome and gestational diabetes: Aggravated complication of pregnancy (Review). Experimental and Therapeutic Medicine.14(2):1271–6.
Yildiz BO, Bolour S, Woods K, Moore A, Azziz R. (2009). Visually scoring hirsutism. Human Reproduction Update.16(1):51– 64.
Zhao R, Zhang W, Ma C, Zhao Y, Xiong R, Wang H, et al. (2021). Immunomodulatory function of vitamin D and its role in autoimmune thyroid disease. Front Immunol.12:574967.
Zhao H, Zhang J, Cheng X, Nie X, He B. (2023). Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment. Journal of Ovarian Research.16(1):1–17.
Downloads
Published
License
Copyright (c) 2024 امحمد عثمان فيدان ، سليمان مصطفى الأطيرش، أسماء محمد القنيدي، رنيم محمد الأطرش، ريان علي بيت المال
This work is licensed under a Creative Commons Attribution 4.0 International License.
